rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-9-7
|
pubmed:abstractText |
Our primary objective was to evaluate the effectiveness and tolerability of intramuscular ziprasidone for impulsivity and agitation in psychiatrically hospitalized children and adolescents. Our secondary objective was to examine demographic and clinical factors associated with treatment response.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1044-5463
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-9
|
pubmed:meshHeading |
pubmed-meshheading:17822344-Adolescent,
pubmed-meshheading:17822344-Adult,
pubmed-meshheading:17822344-Age Factors,
pubmed-meshheading:17822344-Antipsychotic Agents,
pubmed-meshheading:17822344-Child,
pubmed-meshheading:17822344-Child, Preschool,
pubmed-meshheading:17822344-Electrocardiography,
pubmed-meshheading:17822344-Female,
pubmed-meshheading:17822344-Hospitals, Pediatric,
pubmed-meshheading:17822344-Humans,
pubmed-meshheading:17822344-Injections, Intramuscular,
pubmed-meshheading:17822344-Male,
pubmed-meshheading:17822344-Mental Disorders,
pubmed-meshheading:17822344-Piperazines,
pubmed-meshheading:17822344-Psychiatric Department, Hospital,
pubmed-meshheading:17822344-Psychiatric Status Rating Scales,
pubmed-meshheading:17822344-Psychomotor Agitation,
pubmed-meshheading:17822344-Regression Analysis,
pubmed-meshheading:17822344-Retrospective Studies,
pubmed-meshheading:17822344-Sex Factors,
pubmed-meshheading:17822344-Sleep Stages,
pubmed-meshheading:17822344-Thiazoles,
pubmed-meshheading:17822344-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
|
pubmed:affiliation |
Children's Hospital Medical Center, Division of Child and Adolescent Psychiatry, Cincinnati, Ohio 45229-3039, USA. drew.barzman@fuse.net
|
pubmed:publicationType |
Journal Article
|